InSysBio to take part in SMB 2021

events
Conference
May 25, 2021

May 25, 2021

InSysBio announces its participation in Society of Mathematical Biology Annual Meeting (SMB 2021) which is to be held virtually this year June 13-17, 2021. InSysBio team is going to present 4 posters and Oleg Demin Jr is going to give a presentation “Implementation of variability or uncertainty in parameter values to validate QSP models.” and Ivan Borisov is going to give a talk “Constrained Optimization Approach to Predictability Analysis in Bio-Mathematical Modeling.”

Mon, 06/14, 11:30PM - Tue, 06/15, 12:30AM (PDT)

PS03-IMMU

  • (1) “Comparison of different implementations of lymphocyte proliferation in QSP models of immune response” by Oleg Demin

Tue, 06/15 04:15 AM (PDT)

MS06-MFBM

  • Presentation “Implementation of variability or uncertainty in parameter values to validate QSP models.” by Oleg Demin Jr

Wed, 06/16, 11:30PM - Thur, 06/17, 12:30AM (PDT)

PS05-MFBM

  • (6) “Application of different approaches to generate virtual patient populations for QSP model of Erythropoiesis” by Galina Kolesova
  • (7) “Unified approach for in vitro data based parameters estimation” by Veronika Musatova
  • (8) “Specific lysis modeling and parameter extraction from experimental data” by Dmitry Shchelokov

Thur, 06/17, 06:45pm (PDT)

CT09-MFBM

  • Talk “Constrained Optimization Approach to Predictability Analysis in Bio-Mathematical Modeling.” by Ivan Borisov

The presentation in frames of MFBM-MS06 time block is dedicated to the topic “Mathematical and computational methods to augment the reliability of biological models for better decision-making”. Oleg Demin Jr comments on it, “Validation is an important step to test the reliability of the mathematical models including quantitative systems pharmacology (QSP) models. Clinical endpoints for the population of patients are usually used to validate QSP models. For example, percent of responders or mean +/- SD of the particular biomarker. Variability or uncertainty in parameter values should be implemented to describe these endpoints. There are various approaches to extract and implement variability or uncertainty in parameters in model predictions. These methods and cases of their implementation in mechanistic and QSP models will be discussed in the framework of this presentation”.

The talk in frames of MFBM-CT09 time block is named “Constrained Optimization Approach to Predictability Analysis in Bio-Mathematical Modeling.” and Ivan Borisov comments on its topic, "Background: Identifiability analysis is a crucial step in improving reliability and predictability of biological models. Profile Likelihood (PL) is a reliable though computationally expensive approach to identifiability analysis. PL-based algorithm Confidence Intervals by Constraint Optimization (CICO), which was recently published (https://doi.org/10.1371/journal.pcbi.1008495/), reduces computational requirements and increases the accuracy of the estimated parameters’ confidence intervals. The CICO algorithm is available in a free software package LikelihoodProfiler based on Julia (https://github.com/insysbio/LikelihoodProfiler.jl). CICO can be potentially extended to predictability analysis and confidence bands estimation.Objectives: The goal of this study is to examine the application of CICO to estimation of confidence and prediction bands. The analysis was performed on a number of published biological models, including STAT5 Dimerization model, Cancer Taxol Treatment model, etc.Results: The original CICO algorithm can be extended to a broader use-case of confidence bands. The analysis demonstrates good performance characteristics for both identifiable and non-identifiable cases. The approach can be used with complex biological models where each likelihood estimation is computationally expensive and some output values are non-identifiable. Detailed analysis of each model can be found on the GitHub repository likelihoodprofiler-cases https://github.com/insysbio/likelihoodprofiler-cases."

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 120 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

October 2022
MoTuWeThFrSaSu
     
1
2
3
4
5
6
7
8
9
10
11
12
1. 12 Oct 2022 16:07 InSysBio to take part in ACoP13 InSysBio announces its participation in the Thirteenth American Conference on Pharmacometrics (ACoP13) which is to be held in person from October 30th to November 2nd, 2022, at the Gaylord Rockies Resort & Convention Center in Aurora, Colorado. InSysBio team is going to present 7 posters in frames of the Conference
13
14
15
16
17
18
19
20
21
22
23
24
25
1. 25 Oct 2022 14:41 InSysBio to present its ePoster at ECTRIMS 2022 InSysBio team is going to present its poster in frames of 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis which is to be held October 26-28, Amsterdam, the Netherlands. The ePoster is going to be presented in frames of "Pathology and pathogenesis of MS - Neurodegeneration" ePoster Area, October 26
26
27
28
29
30
31
      
Upcoming Events
Tags
Latest News
22.02
14th InSysBio’s Annual Internal Scientific Meeting
24.01
InSysBio to present the new Plugin for Sublime Text and Heta compiler Online
07.12
InSysBio to release public beta of fIVE Calculator
06.04
InSysBio to release Immune Response Template 3.6.2 for QSP modeling
16.01
InSysBio team to publish the new article “Receptor occupancy assessment and interpretation in terms of quantitative systems pharmacology: nivolumab case study”